170 related articles for article (PubMed ID: 31258777)
1. The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma.
Huang X; Hong C; Peng Y; Yang S; Huang L; Liu C; Chen L; Chu L; Xu L; Xu Y
J Cancer; 2019; 10(12):2687-2693. PubMed ID: 31258777
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer.
Qiu B; Chu LY; Li XX; Peng YH; Xu YW; Xie JJ; Chen XY
Onco Targets Ther; 2020; 13():12131-12139. PubMed ID: 33262611
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
4. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
[TBL] [Abstract][Full Text] [Related]
5. Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.
Liu CT; Xu YW; Guo H; Hong CQ; Huang XY; Luo YH; Yang SH; Chu LY; Li EM; Peng YH
Gut Liver; 2020 Nov; 14(6):727-734. PubMed ID: 31822054
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of serum insulin-like growth factor binding protein 7 in gastric cancer.
Liu CT; Wu FC; Zhuang YX; Huang XY; Li XH; Qu QQ; Peng YH; Xu YW; Chen SL; Huang XC
PeerJ; 2023; 11():e15419. PubMed ID: 37304887
[TBL] [Abstract][Full Text] [Related]
7. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
[TBL] [Abstract][Full Text] [Related]
9. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Huang Z; Zhou B; Li Z; Liu C; Zheng C; Zeng R; Hong C; Xu L; Li E; Peng Y; Xu Y
Cancer Biomark; 2020; 29(1):139-149. PubMed ID: 32623391
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Zhou JH; Zhang B; Kernstine KH; Zhong L
World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
[TBL] [Abstract][Full Text] [Related]
13. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection.
Chen Z; Xing J; Zheng C; Zhu Q; He P; Zhou D; Li X; Li Y; Qi S; Ouyang Q; Zhang B; Xie Y; Ren J; Cao B; Zhu S; Huang J
Front Oncol; 2023; 13():1161489. PubMed ID: 37251926
[TBL] [Abstract][Full Text] [Related]
15. Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma.
Liu W; Wang Q; Chang J; Bhetuwal A; Bhattarai N; Zhang F; Tang J
Clin Proteomics; 2022 May; 19(1):18. PubMed ID: 35610567
[TBL] [Abstract][Full Text] [Related]
16. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
Chen J; Chen M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
[TBL] [Abstract][Full Text] [Related]
17. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.
Chai AWY; Cheung AKL; Dai W; Ko JMY; Lee NPY; Chan KT; Law SY; Lung ML
Cancer Biomark; 2018 Feb; 21(3):583-590. PubMed ID: 29278876
[TBL] [Abstract][Full Text] [Related]
20. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
